Endocrinology

A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus

Conditions:   Sarcoidosis;   Diabetes Mellitus
Interventions:   Diagnostic Test: Venous blood sample;   Diagnostic Test: Ultrasound of pancreas
Sponsor:   University of Alabama at Birmingham
Recruiting
ClinicalTrials.gov: Endocrinology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

January 16, 2019 / by / in
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: Cenerimod 0.5 mg;   Drug: Cenerimod 1 mg;   Drug: Cenerimod 2 mg;   Drug: Cenerimod 4 mg;   Drug: Placebo
Sponsor:   Idorsia Pharmaceuticals Ltd.
Not yet recruiting
ClinicalTrials.gov: Endocrinology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 26, 2018 / by / in
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus

Conditions:   Diabetes Mellitus, Type 2;   Cardiovascular Diseases
Interventions:   Drug: Dapagliflozin 10mg;   Drug: Saxagliptin 5mg;   Drug: Placebo Oral Tablet
Sponsor:   Sabyasachi Sen
Recruiting
ClinicalTrials.gov: Endocrinology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 14, 2018 / by / in
A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: AG019 – Low Dose;   Drug: Teplizumab;   Drug: Placebo-AG019;   Drug: Placebo-Teplizumab;   Biological: AG019 – High Dose;   Biological: AG019 – Low or High Dose
Sponsors:   Intrexon T1D Partners, LLC;   ActoBio Therapeutics;   TFS Trial Form Support
Recruiting
ClinicalTrials.gov: Endocrinology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 24, 2018 / by / in